This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

11 Stocks to Watch: Immucor, Baidu

NEW YORK ( TheStreet) -- Immucor (BLUD), the blood transfusion systems provider, agreed to be bought by investment funds managed by TPG Capital in a deal valued at $1.97 billion.

Under the deal, Immucor shareholders will receive $27 in cash for each share of Immucor common stock they own, representing a premium of about 30.2% over the closing share price on July 1, the last full trading day before Tuesday's announcement.

Baidu (BIDU - Get Report), China's biggest search engine by revenue, on Monday announced a partnership with Microsoft (MSFT - Get Report) that would allow its users to see English-language search results generated by Bing, Microsoft's search engine. Microsoft shares were up 0.4% to $26.11 in premarket trading Tuesday, and Baidu shares were rising 2.5% to $146.98.

Energy Transfer Equity (ETE - Get Report) raised its offer to acquire natural gas company Southern Union (SUG) for about $5.1 billion in cash. Under the new deal, Southern Union shares are valued at $40 a share, higher than Energy Transfer's mid-June bid of $33 a share, and above a competing offer from Williams (WMB - Get Report) of $39 a share. Shares of Southern Union were rising 2.3% to $41.30, while Williams was falling 0.8% to $30.51.

The initial cleanup along the oil-fouled Yellowstone River could be tested Tuesday as rising waters make it harder for Exxon Mobil (XOM - Get Report) to get to areas damaged by the crude spilled from a company pipeline. Shares were down 0.7% to $81.42.

A Pfizer (PFE - Get Report) stop-smoking drug Chantix increases the risk of cardiovascular events such as heart attacks, according to researchers who analyzed multiple trials involving the drug. Shares were down 0.5% to $20.65.

Specialty chemicals company OM Group (OMG) agreed to buy German advanced materials and specialty magnetic company Vacuumschmelze GmbH for about € 700 million ($1 billion). Shares were rising 0.4% to $41.

Novartis (NVS - Get Report) announced that it will submit for worldwide regulatory approval its advanced breast cancer drug Afinitor by the end of this year, following positive results from an interim study of the drug. Shares were up 0.1% to $61.21.

Construction company Tutor Perini (TPC - Get Report) acquired Lunda Construction in a deal valued at $163.5 million and electrical and mechanical services and systems company GreenStar for $208.4 million.

-- Written by Andrea Tse in New York.

>To contact the writer of this article, click here: Andrea Tse.


>> Paulson Sells Big Bank of America Stake
>> 3 Companies That Are Potential Buyout Targets
Copyright 2011 Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
OMG $0.00 0.00%
BIDU $175.22 0.00%
ETE $13.07 0.00%
MSFT $49.94 0.00%
NVS $74.12 0.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs